000 01222 a2200301 4500
005 20250518010046.0
264 0 _c20190222
008 201902s 0 0 eng d
022 _a1399-3062
024 7 _a10.1111/tid.13028
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLewis, Jessica D
245 0 0 _aComparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients: A reply to Jorgenson et al.
_h[electronic resource]
260 _bTransplant infectious disease : an official journal of the Transplantation Society
_c02 2019
300 _ae13028 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAnti-Bacterial Agents
650 0 4 _aDaptomycin
650 0 4 _aEnterococcus faecium
650 0 4 _aHumans
650 0 4 _aLiver Transplantation
650 0 4 _aRisk Factors
650 0 4 _aVancomycin
700 1 _aBarros, Andrew J
700 1 _aSifri, Costi D
773 0 _tTransplant infectious disease : an official journal of the Transplantation Society
_gvol. 21
_gno. 1
_gp. e13028
856 4 0 _uhttps://doi.org/10.1111/tid.13028
_zAvailable from publisher's website
999 _c29046511
_d29046511